Africa's genomics biobank for drug discovery
54gene was a Nigerian genomics company that built Africa's first large-scale biobank to accelerate drug discovery for diseases prevalent on the continent. Raised $45M and was one of Africa's most prominent healthtech stories before winding down operations in 2023.
Founded
2019Headquarters
Lagos, Nigeria / Washington DCFounders
Abasi Ene-ObongValuation
Wound down (2023)Key Investors
Adjuvant Capital, Y Combinator, Pioneer FundDigital health infrastructure for Africa
Health and wellness e-commerce for women across East Africa
Real-time delivery of blood, oxygen, and vaccines to hospitals